MARA
Marathon Digital Holdings, Inc.
There isn't enough reported data to score MARA yet.
NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
MARA Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| N/A | |
| N/A |
MARA's revenue and profitability are currently weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like MARA.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
MARA PE Valuation
MARA has no meaningful PE right now: it lost money over the past year.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
MARA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| -- | |
| Limited | |
| Low |
Analysts expect MARA's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
MARA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$7.88 | -465% |
| Q2 2026 | -$8.89 | -705% |
| Q1 2026 | -$5.45 | -$4.36 |
| Q4 2025 | -$3.69 | -315% |
| Q3 2025 | $2.16 | +148% |
| Q2 2025 | $1.47 | -10% |
| Q1 2025 | -$1.09 | -149% |
| Q4 2024 | $1.72 | +87% |
MARA has swung to a loss: it lost $7.88 per share over the past year, after a profit the year before.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over MARA on earnings quality, reporting a profit while its opponent remains loss making.
MARA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $164.2M | -35% |
| Q2 2026 | $174.9M | -27% |
| Q1 2026 | $174.6M | -18% |
| Q4 2025 | $202.3M | -5.6% |
| Q3 2025 | $252.4M | +92% |
| Q2 2025 | $238.5M | +64% |
| Q1 2025 | $213.9M | +29% |
| Q4 2024 | $214.4M | +37% |
MARA's revenue has slid since its 2025 peak: $164M last quarter, down 35% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 108% | +89 points |
| Q2 2026 | -298% | -583 points |
| Q1 2026 | -608% | -355 points |
| Q4 2025 | -697% | -856 points |
| Q3 2025 | 19% | +150 points |
| Q2 2025 | 285% | +445 points |
| Q1 2025 | -253% | -477 points |
| Q4 2024 | 159% | +41 points |
MARA has the edge over NVO on profitability, with a higher operating margin.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO has the edge over MARA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO's operating margin was 34% last quarter, down 9 points from the same quarter a year ago, near the bottom of its range since 2019.
MARA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$263.6M | +$20.3M |
| Q2 2026 | -$238.5M | +$43.8M |
| Q1 2026 | -$327M | -$72.7M |
| Q4 2025 | -$389.2M | +$110.7M |
| Q3 2025 | -$283.9M | -$85.8M |
| Q2 2025 | -$282.4M | -$150M |
| Q1 2025 | -$254.3M | -$156.9M |
| Q4 2024 | -$499.9M | -$407M |
MARA's free cash flow was −$1.2B over the past year, against −$1.3B the year before. Free cash flow isn't a meaningful measure for financial services companies like MARA.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over MARA on cash generation, producing positive trailing cash flow while its opponent burns cash.
MARA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +30% | +115M shares |
| 1 year | +13% | +55.5M shares |
| 3 years | +212% | +337M shares |
| 5 years | +416% | +400M shares |
MARA has 496M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $13.7M |
| Q2 2026 | $7.7M |
| Q1 2026 | $7.5M |
| Q4 2025 | $3.7M |
| Q3 2025 | $7.7M |
| Q2 2025 | $15.2M |
| Q1 2025 | $20.4M |
| Q4 2024 | $5.9M |
MARA spent $33M buying back its own shares over the past year, down 34% from the year before.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over MARA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
MARA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 2.5x | Moderate |
| Q4 2024 | 2.9x | Moderate |
| Q3 2024 | 0.9x | Very low |
| Q2 2024 | 0.1x | Very low |
| Q1 2024 | 0.0x | Very low |
| Q4 2023 | -0.1x | Net Cash |
| Q3 2023 | 2.6x | Moderate |
MARA's net debt is about 2.1 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like MARA.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
MARA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.4 | Neutral |
| Stochastic | 10.2 | Oversold |
MARA's weekly RSI is 38 (neutral) and its Stochastic is 10 (oversold).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
MARA PE vs Financial Services Sector
| Metric | MARA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
MARA has no meaningful PE right now: it lost money over the past year.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
MARA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.54 | 16% below |
| 20 week MA | $10.3 | 30% below |
| 50 week MA | $10.6 | 32% below |
| 100 week MA | $13.3 | 46% below |
| 200 week MA | $14.4 | 50% below |
MARA is in a downtrend: it's below all five of its weekly moving averages, and 50% below its 200-week average.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has the edge over MARA on trend strength, trading above more of its moving averages.
MARA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $0.90 | $10.9 | +1113% |
| 2021 | $10.9 | $38.1 | +249% |
| 2022 | $38.1 | $3.62 | -91% |
| 2023 | $3.62 | $23.5 | +549% |
| 2024 | $23.5 | $18.4 | -21% |
| 2025 | $18.4 | $9.59 | -48% |
| 2026 YTD | $9.59 | $7.20 | -25% |
MARA's yearly returns have swung widely, from +1113% in 2020 to −91% in 2022. It's down 25% so far in 2026.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over MARA on returns for 2026, with the stronger performance.